UBS Group AG - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 107 filers reported holding ADMA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$816,737
-22.0%
228,139
-19.7%
0.00%
Q2 2023$1,047,761
-17.6%
283,946
-26.1%
0.00%
Q1 2023$1,271,205
-39.6%
384,050
-29.2%
0.00%
-100.0%
Q4 2022$2,104,931
+1266.8%
542,508
+755.3%
0.00%
Q3 2022$154,000
+633.3%
63,430
+456.6%
0.00%
Q1 2022$21,0000.0%11,395
-38.2%
0.00%
Q3 2021$21,000
+162.5%
18,435
+270.6%
0.00%
Q2 2021$8,000
-77.8%
4,975
-75.6%
0.00%
Q1 2021$36,000
-16.3%
20,413
-6.7%
0.00%
Q4 2020$43,000
+330.0%
21,876
+426.9%
0.00%
Q3 2020$10,000
-90.8%
4,152
-88.8%
0.00%
Q2 2020$109,000
+9.0%
37,140
+6.3%
0.00%
Q1 2020$100,000
-56.7%
34,934
-39.4%
0.00%
Q4 2019$231,000
-19.2%
57,675
-10.2%
0.00%
Q3 2019$286,000
+1405.3%
64,224
+1184.7%
0.00%
Q2 2019$19,000
+280.0%
4,999
+251.1%
0.00%
Q1 2019$5,000
-99.4%
1,424
-99.6%
0.00%
Q4 2018$838,000
+1943.9%
350,672
+5208.4%
0.00%
Q3 2018$41,000
+36.7%
6,606
-2.0%
0.00%
Q2 2018$30,000
+114.3%
6,740
+119.3%
0.00%
Q1 2018$14,000
+40.0%
3,073
-9.6%
0.00%
Q3 2017$10,000
+900.0%
3,400
+2025.0%
0.00%
Q2 2016$1,000
-96.2%
160
-95.0%
0.00%
Q1 2016$26,000
+225.0%
3,193
+248.6%
0.00%
Q2 2015$8,0009160.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital LLC 3,608,171$8,624,0002.44%
Broadfin Capital, LLC 4,226,077$10,100,0001.33%
MORGENS WATERFALL VINTIADIS & CO INC 400,000$956,0000.85%
Consonance Capital Management LP 4,588,352$10,966,0000.81%
Perceptive Advisors 6,521,102$14,542,0000.55%
Diag Capital Management, LP 182,100$435,0000.50%
683 Capital Management, LLC 805,000$1,924,0000.12%
ARDSLEY ADVISORY PARTNERS LP 50,000$120,0000.03%
AVANTAX ADVISORY SERVICES, INC. 65,050$156,0000.03%
PURA VIDA INVESTMENTS, LLC 37,170$89,0000.02%
View complete list of ADMA BIOLOGICS INC shareholders